On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Becoming a CBD Wellness Product Leader as Plant-Based Health Market Explodes

  • Wildflower Brands is working hard to establish a solid retail network in the U.S. and Canada
  • The company has achieved a number of strategic partnerships and acquisitions, making Wildflower Brands wellness products available in 600 locations across America
  • The company also operates four premier cannabis locations in British Columbia under its subsidiary, City Cannabis Corp.

The global hemp-derived CBD oil market reached $591 million in 2018 and is anticipated to grow to $22 billion by 2022 (http://ibn.fm/yPoHn). Wellness and health products are expected to drive this growth as awareness about the benefits of CBD oil continues to increase.

CBD oil was first highlighted in the early 2010s, when reports emerged of it being used in the treatment of children with epilepsy. Since then, multiple additional health benefits have been researched and confirmed. CBD oil has taken off commercially, especially after the passage of the federal Farm Bill. The changing legislative framework has made it much easier to grow hemp and to extract the valuable resource from it. Today, CBD oil is being added to beverages, edibles, topical creams, oils, waxes and pills.

Companies like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) are working hard to establish their CBD market leadership amid this popularity boom. A cannabis company focused on the development and design of branded products in the sector, Wildflower is focused on growing its retail distribution network throughout Canada and the U.S. Recently, the company completed a strategic acquisition of City Cannabis Corp., which will give it access to four retail cannabis stores in Vancouver, British Columbia, two of which were opened in August 2019 (http://ibn.fm/fIf56).

Simultaneously, Wildflower Brands is actively seeking opportunities to maximize its retail presence in the U.S. Its wellness products have been launched in over 260 Dillard’s department stores throughout the country (http://ibn.fm/GejdN). The initial purchase order is significant, because it enables Wildflower products to enter several new states, according to Wildflower CEO William McLean.

Earlier in 2019, Wildflower Brands launched a CBD-infused product collaboration with wellness guru Joel Warren, making the products available at Warren’s Saks Fifth Avenue salon (http://ibn.fm/Erjn8). In addition, the company initiated a strategic New York expansion that made the products available at 20 premium health and wellness stores throughout Manhattan.

Following the latest strategic partnerships and retail collaborations, the Wildflower Brands CBD-infused products can now be found in 600 locations across America.

The marketplace is forecast to explode in the near future, and the entities that have an already well-established and recognizable brand will benefit the most, as McLean stated in a news release. “Our strategy is to build off our established brand equity in these key markets and partner with brands that can catapult us into becoming a household name,” he concluded.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

From Our Blog

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Helomics Leverages Cutting-Edge Tech and Datasets to Improve Cancer Outcomes

May 22, 2020

POAI subsidiary Helomics helps oncologists individualize cancer treatment using patient-derived tumor models to improve outcomes Helomics’ tumor genomic and drug response database is one of the largest in the world with over 150,000 tumors across 137 cancer types Expected CAGR of 10.3% from 2018-2024 for oncology segment of precision medicine industry The relationship between a […]

Rotate your device 90° to view site.